APOLLODX, LLC

Medtech · Private

Handheld electrochemical biosensor using DNA aptamers to detect drug metabolites in urine for patient medication adherence monitoring in clinical trials

Grants
$324K
2 awards
Sector median: 1
Raised
—
No Form D on record
Contracts
—
No federal contracts on record
Patents
6
0 granted · 6 pending
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Federal grantDepartment of Health and Human Services · Phase I · Development of a DNA Aptamer-Based Electrochemical Assay for Acetazolamide in Urine Using a Handheld Biosensor for Compliance Validation in Clinical Drug Trials$225,000
Federal grantDepartment of Agriculture · In HARVARD'S Publication,roadmap To Pandemic Resilience, Danielle Allen And Co-authors Clearly Stated That For "a Safe Social Reopening" Of The US, There Needs To Be 5 Million Coronavirus Tests Performper Dayin Early June And 20 Million Per Day In, Ideally, Late July.nobel Laureate Economist Paul Romer Stated That The Number Is 35 Million Tests Per Day.as Of 8/29/20, The Cdc Reported 82,779,999 Tests Have Been Performed In The US Since The Beginning.this Total Is Far Short Of These Prominent$99,332
Federal grant · SBIR/STTR

Peer position

Medtech · 4531 companies · ranked on federal contract value
Medtech companies ranked by federal contract value
#CompanyContractsDisclosed equity
1578SIGT, LLC——
1579FRIA INC.—$30K
1580PULSETHERA CORP——
1581APOLLODX, LLC——
1582NeuroSmart Inc.——
1583Peritas AI Inc.—$6.4M
1584NEOVATIVE, INC.——

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Patents

USPTO · 0 granted of 6
  • Test Strip For Diagnostic Testingapplication
  • Systems And Methods For Diagnostic Testingapplication
  • Devices, Systems, And Methods For Diagnostic Testingapplication
  • Test Strip For Diagnostic Testingapplication
  • Systems And Methods For Diagnostic Testingapplication
  • Systems And Methods For Diagnostic Testingapplication

Regulatory activity · Medtech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.